The trajectory of copyright's flagship drug presents a interesting case for stakeholders in the medicinal sector. While initially a tremendous success, producing billions, the exclusivity lapse and the subsequent https://adult341236.thechapblog.com/40572914/sildenafil-and-pharma-a-hazardous-play